For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220406:nRSF4657Ha&default-theme=true
RNS Number : 4657H Spire Healthcare Group PLC 06 April 2022
6 April 2022
Spire Healthcare Group plc
Notification and public disclosure of transaction by persons discharging
managerial responsibility and persons closely associated with them
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name Harbant Samra
2 Reason for the notification
a) Position/status Interim Chief Financial Officer
b) Initial notification /Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Spire Healthcare Group plc
b) LEI 213800IBJPW3SE2RA350
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary shares of 1 pence each
Identification code
GB00BNLPYF73
b) Nature of the transaction Exercise of nil-cost options over ordinary shares vesting under the Spire
Healthcare Group plc Long Term Incentive Plan 2014.
Following exercise of his award over 66,762 shares Mr Samra elected to sell
31,489 shares to satisfy taxes, social security and associated dealing costs.
He has retained the balance of ordinary shares.
c) Price(s) and volume(s) Price(s) Volume(s)
Nil 66,762
246.0 pence 31,489
d) Aggregated information £77,463
- Aggregated volume
- Price
e) Date of the transaction 2022-04-04
f) Place of the transaction XLON
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHGIGDSXUGDGDL